Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?

Published:2020-01-28 Issue:8 Volume:146 Page:2305-2314
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Masterson Liam¹²^ORCID,Howard James³,Gonzalez‐Cruz Jazmina⁴,Jackson Christopher¹,Barnett Catherine¹,Overton Lewis¹,Liu Howard¹,Ladwa Rahul¹,Simpson Fiona⁴,McGrath Margie¹,Wallwork Ben¹⁵,Jones Terry⁶,Ottensmeier Christian⁷,Chua Melvin L.K.⁸^ORCID,Perry Chris¹⁵,Khanna Rajiv⁹,Panizza Benedict¹⁵,Porceddu Sandro¹⁵,Lechner Matt¹⁰¹¹

Affiliation:

1. Department of Head & Neck OncologyPrincess Alexandra Hospital Brisbane Australia

2. Department of ENTUniversity of Cambridge Cambridge United Kingdom

3. University of Cardiff Cardiff United Kingdom

4. Diamantina Institute, University of Queensland Woolloongabba QLD Australia

5. Faculty of MedicineUniversity of Queensland St. Lucia Australia

6. Liverpool Head & Neck CentreUniversity of Liverpool Liverpool United Kingdom

7. Department of MedicineUniversity of Southampton Southampton UK

8. Divisions of Radiation Oncology & Medical Science, National Cancer Centre Singapore Singapore

9. QIMR Berghofer Medical Research Institute Brisbane City QLD Australia

10. UCL Cancer InstituteUniversity College London London United Kingdom

11. Barts Health NHS Trust London United Kingdom